NMC Health (LON:NMC) had its price objective decreased by Jefferies Financial Group from GBX 1,300 ($17.10) to GBX 500 ($6.58) in a research note released on Monday morning, Stock Target Advisor reports. Jefferies Financial Group currently has an underperform rating on the stock.
Several other equities analysts also recently weighed in on NMC. Barclays reaffirmed an overweight rating on shares of NMC Health in a research note on Tuesday, January 7th. Goldman Sachs Group dropped their price objective on NMC Health from GBX 4,250 ($55.91) to GBX 4,170 ($54.85) and set a buy rating for the company in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. NMC Health has a consensus rating of Buy and an average target price of GBX 3,236.25 ($42.57).
NMC opened at GBX 938.40 ($12.34) on Monday. The company has a debt-to-equity ratio of 165.90, a current ratio of 1.70 and a quick ratio of 1.43. The business has a 50 day simple moving average of GBX 1,120.94 and a 200-day simple moving average of GBX 2,038.36. The stock has a market capitalization of $1.96 billion and a P/E ratio of 7.27. NMC Health has a 12 month low of GBX 677.01 ($8.91) and a 12 month high of GBX 3,059 ($40.24).
About NMC Health
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
Recommended Story: Overbought
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.